Friday, 17:32, 26/02/2021
VOV.VN - Vietnamese engineers boast basic knowledge, diligence, and a strong work ethic, according to Iri Kazuaki, director of Dentsu Japan Company.
Vietnamese engineers work at the Dentsu Japan s office in Tokyo (Photo: VNA)
Kazuaki emphasised that after working for the company, Vietnamese engineers are among those who are quickest to acquire new techniques and skills, whilst they are also able to undertake a variety of challenging tasks.
He described how Dentsu Japan Company has also focused on training Vietnamese engineers, with experienced Japanese engineers being responsible for providing technical instructions for them, adding that the presence of Vietnamese engineers has made a number of important contributions to the company s operations in recent times.
Japan Health System Improves Patient Safety with Adoption of NRFit™ Neuraxial Connectors, GEDSA Announces
Share Article
NRFit offers a safer connector for healthcare providers
Around the world, hospitals are doing the right thing by adopting connectors made to a unified global standard. One near miss, patient injury or death is one too many. COLUMBUS, Ohio (PRWEB) February 25, 2021 All hospitals across Japan have completed adoption of ISO-compliant NRFit™ neuraxial connectors designed to improve patient safety by reducing the risk of medical device misconnections, the Global Enteral Device Supplier Association (GEDSA) announced today. NRFit replaces legacy connectors that are prone to wrong-route delivery of medication, which can result in patient injury or death.
Share this article
CAMBRIDGE, Mass., Feb. 25, 2021 /PRNewswire/
Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose of bettering the lives of people impacted by kidney disease, today reported financial results for the fourth quarter and full-year ended December 31, 2020 and provided business updates. The Company will host a conference call today, Thursday, February 25, 2021, at 9:00 a.m. Eastern Time.
Akebia also announced a $60 million non-dilutive transaction with an entity managed by HealthCare Royalty Management, LLC (HCR), to monetize the Company s rights to receive royalties and sales milestones on vadadustat net sales under its collaboration agreement with Mitsubishi Tanabe Pharma Corporation (MTPC). MTPC has the exclusive rights to commercialize vadadustat in Japan, where it is currently marketed under the trade name Vafseo™ (vadadustat), and certain other Asian countries. Under the terms of the agreement with HCR, Akebia receive
Daiichi Sankyo and LYSA-LYSARC-CALYM Enter Research Collaboration for Valemetostat in Patients with Relapsed/Refractory B-Cell Lymphoma yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.
Japan’s Ministry of Health has said it will give 44,200,000 yen (£295,590) to the families of anyone who dies as a result of the Covid-19 vaccine. Families can also receive money to cover funeral costs up to 209,000 yen (£1,400). The ministry has offered the compensation for a long time – and for any kind of vaccination, not just Covid-19 jabs – but it was recently highlighted at a budget meeting by the country’s health minister, Norihisa.